NCT00352963 - Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age). | Biotech Hunter

Enrollment

480

Participants

Timeline

Start Date

September 30, 2003

Study Completion Date

July 16, 2004

Conditions

PoliomyelitisTetanusAcellular PertussisHepatitis BDiphtheria

Interventions

BIOLOGICAL

Study vaccines: IH+Hib-MenC/NVC; Control: IH+Meningitec

Trial Locations (22)

4009

GSK Investigational Site, Almeira

14004

GSK Investigational Site, Córdoba

28007

GSK Investigational Site, Madrid

28040

GSK Investigational Site, Marid

28041

GSK Investigational Site, Madrid

28047

GSK Investigational Site, Madrid

28905

GSK Investigational Site, Getafe

28922

GSK Investigational Site, Alcorcón

28935

GSK Investigational Site, Móstoles/Madrid

29010

GSK Investigational Site, Málaga

41013

GSK Investigational Site, Seville

41071

GSK Investigational Site, Seville

47010

GSK Investigational Site, Valladolid

48013

GSK Investigational Site, Bilbao

08916

GSK Investigational Site, Badalona

08025

GSK Investigational Site, Barcelona

08035

GSK Investigational Site, Barcelona

08950

GSK Investigational Site, Barcelona

09005

GSK Investigational Site, Burgos

Unknown

GSK Investigational Site, Leganés

GSK Investigational Site, Vélez-Málaga

07014

GSK Investigational Site, Palma de Mallorca